Japanese Journal of Clinical Oncology

The Japanese Journal of Clinical Oncology (JJCO) is a monthly peer-reviewed journal published by Oxford University Press that covers clinical oncology with a particular emphasis on the Asian region, founded in 1971 as Japan's first English-language journal of cancer clinical research, with a 2025 impact factor of 2.5（Japanese Journal of Clinical Oncology，简称 JJCO）是由 Oxford University Press 出版的月刊，覆盖临床肿瘤学并侧重亚洲地区，1971 年创刊，为日本首本以英文刊发癌症临床研究的期刊，2025 年影响因子为 2.5。

Scope

• Medical oncology, clinical trials and radiology内科肿瘤学、临床试验与放射影像学。
• Surgery, basic research and epidemiology外科、基础研究与流行病学。
• Palliative care and supportive oncology姑息治疗与支持治疗。
• Original Articles, Case Reports, Clinical Trial Notes, Cancer Genetics Reports, Epidemiology Notes, Technical Notes, Short Communications and Letters原创论文、病例报告、临床试验札记、肿瘤遗传学报告、流行病学札记、技术札记、短通讯与读者来信。
• Solicited reviews are published, and interim reports on trial design are welcome另出版约请综述，亦欢迎关于试验设计的阶段性报告。

History

• The journal was founded in 1971 by Masaru Kuru, the third president of the National Cancer Center该刊 1971 年由国立癌症中心第三任理事长 Masaru Kuru 创办。
• Its editorial office was housed in the Foundation for Promotion of Cancer Research, then affiliated with the National Cancer Center, and each president of that centre served as editor-in-chief编辑部设于当时隶属国立癌症中心的癌症研究促进基金会，历任主编均由该中心理事长担任。
• Oxford University Press became the publisher in 1997, and the journal became independent of its sponsorship in 2007Oxford University Press 自 1997 年起出版该刊，2007 年该刊脱离资助实现独立。
• It has been published online only since January 2018 and is a sister journal of the Journal of the National Cancer Institute, with a 2025 impact factor of 2.5该刊自 2018 年 1 月起仅在线出版，并与（Journal of the National Cancer Institute）结为姊妹刊，2025 年影响因子为 2.5。

Editors

• The editor-in-chief is Hideo Kunitoh of the Japanese Red Cross Medical Center in Tokyo现任主编为（Japanese Red Cross Medical Center）的 Hideo Kunitoh。
• Tadao Kakizoe serves as emeritus editor-in-chief, and the editorial board includes Yasushi Goto and Yosuke UchitomiTadao Kakizoe 任荣休主编，编委包括 Yasushi Goto 与 Yosuke Uchitomi。
• The board draws its members chiefly from Japanese cancer centres and universities编委会成员主要来自日本的癌症中心与大学。
• Manuscripts are peer reviewed, with a median time from submission to first decision of about six days稿件经同行评审，从投稿到初审决定的中位时间约为六天。